Actively Recruiting
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
Led by Ethos Research & Development · Updated on 2024-09-19
75
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific biomarkers through changes in urinary biomarker scores may solidify the necessity for identifying deficiencies to create an individualized treatment plan for pain patients. This study aims to evaluate the effect of biomarker-guided supplementation on the three categories of urinary biomarkers using targeted ingredients specifically designed for oxidative stress, inflammation, and nerve health. This study provides subjects with one of three nutritional supplement formulas based on their specific urinary biomarker test results and assesses changes in their urinary biomarker levels and their quality of life as it relates to their pain over a 3-month period.
CONDITIONS
Official Title
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Previously submitted a urinary biomarker sample and agreed to be contacted for research.
- Seeking treatment for chronic pain with symptoms lasting 3 months or more.
- Able to take oral medication and willing to follow the supplement regimen.
You will not qualify if you...
- Diagnosis of bacterial or viral infection during or within 3 months before the study.
- Severe or untreated psychiatric disorders or hospitalization for psychiatric reasons within 1 year before screening.
- History of cancer within 5 years before screening.
- Pregnant, breastfeeding, or planning pregnancy during the study.
- Known allergy or sensitivity to ingredients in the study supplements.
- Dietary restrictions preventing consumption of any study supplement ingredients.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ethos Research and Development
Newport, Kentucky, United States, 41071
Actively Recruiting
Research Team
B
Brianna Krause, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here